Wu Hong-Fei, Wang Shi-Chong, Huang Jin-Bo, Huo Jia-Li, Shao Ying-Qi, Ren Xiang, Li Xing-Xin, Wang Min, Nie Neng, Zhang Jing, Jin Peng, Ge Mei-Li, Zheng Yi-Zhou
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300020, China.
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300020, China,E-mail:
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023;31(4):1125-1132. doi: 10.19746/j.cnki.issn.1009-2137.2023.04.030.
To explore the difference of lymphocyte subsets in peripheral blood (PB) between aplastic anemia (AA) and hypoplastic myelodysplastic syndrome (hypo-MDS) patients, meanwhile to compare the clinical parameters obtained from PB and bone marrow (BM).
The lymphocyte subsets in hypo-MDS (=25) and AA (=33) patients were investigated by flow cytometry. Meanwhile, the differences in PB cell counts, biochemical indicators, BM cell counts and abnormal chromosomes between the two groups were analyzed.
The percentage of CD8T cells in AA group was significantly higher than that in hypo-MDS group (=0.001), while the percentage of CD4 T cells and the CD4/CD8 ratio in AA group were obviously lower than those in hypo-MDS group (=0.015 and 0.001, respectively). Furthermore, the proportion of CD4 and CD8 activated T (TA) cells, and memory Tregs in AA group was distinctly lower than those in hypo-MDS group (=0.043, 0.015 and 0.024, respectively). Nevertheless, the percentage of CD8 naive T (TN) cells in AA patients was remarkably higher (=0.044). And hypo-MDS patients had declined lymphocyte counts (=0.025), increased levels of total bilirubin (TBil), lactate dehydrogenase (LDH), vitamin B12 and proportion of BM blasts than AA patients (=0.019, 0.023, 0.027 and 0.045, respectively).
In this study it was confirmed that the percentages of CD4 and CD8 TA cells, memory Tregs and CD8 TN cells were significantly different between AA and hypo-MDS patients, which provide an essential basis for the identification of these two diseases.
探讨再生障碍性贫血(AA)与低增生骨髓增生异常综合征(低增生MDS)患者外周血淋巴细胞亚群的差异,同时比较外周血和骨髓获得的临床参数。
采用流式细胞术检测低增生MDS患者(n = 25)和AA患者(n = 33)的淋巴细胞亚群。同时,分析两组患者外周血细胞计数、生化指标、骨髓细胞计数及异常染色体的差异。
AA组CD8T细胞百分比显著高于低增生MDS组(P = 0.001),而AA组CD4 T细胞百分比及CD4/CD8比值明显低于低增生MDS组(分别为P = 0.015和0.001)。此外,AA组CD4和CD8活化T(TA)细胞及记忆性调节性T细胞比例明显低于低增生MDS组(分别为P = 0.043、0.015和0.024)。然而,AA患者CD8初始T(TN)细胞百分比显著更高(P = 0.044)。与AA患者相比,低增生MDS患者淋巴细胞计数下降(P = 0.025),总胆红素(TBil)、乳酸脱氢酶(LDH)、维生素B12水平升高,骨髓原始细胞比例增加(分别为P = 0.019、0.023、0.027和0.045)。
本研究证实AA与低增生MDS患者CD4和CD8 TA细胞、记忆性调节性T细胞及CD8 TN细胞百分比存在显著差异,为这两种疾病的鉴别提供了重要依据。